Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in VTVT held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Samsara BioCapital, LLC | 298K | $11.8M | 0.0% | 3.544% | 1.15% |
| 2 | FMR LLC | 260K | $10.3M | -3.1% | 3.091% | 0.00% |
| 3 | MILLENNIUM MANAGEMENT LLC | 206K | $8.2M | β | 2.449% | 0.01% |
| 4 | Siren, L.L.C. | 163K | $6.5M | 0.0% | 1.935% | 0.18% |
| 5 | BAKER BROS. ADVISORS LP | 148K | $5.9M | 0.0% | 1.761% | 0.03% |
| 6 | Trails Edge Capital Partners, LP | 140K | $5.5M | -39.6% | 1.657% | 1.27% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 109K | $4.3M | β | 1.293% | 0.00% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 33K | $1.3M | +16.6% | 0.390% | 0.00% |
| 9 | NORTHERN TRUST CORP | 18K | $716K | +12.5% | 0.214% | 0.00% |
| 10 | VANGUARD FIDUCIARY TRUST CO | 16K | $640K | β | 0.191% | 0.00% |
| 11 | 683 Capital Management, LLC | 16K | $635K | -12.4% | 0.190% | 0.05% |
| 12 | MARSHALL WACE, LLP | 13K | $531K | β | 0.159% | 0.00% |
| 13 | GOLDMAN SACHS GROUP INC | 13K | $529K | +141.4% | 0.159% | 0.00% |
| 14 | BlackRock, Inc. | 13K | $500K | +18.8% | 0.150% | 0.00% |
| 15 | STATE STREET CORP | 11K | $423K | β | 0.127% | 0.00% |
| 16 | Brevan Howard Capital Management LP | 8K | $299K | β | 0.089% | 0.00% |
| 17 | Pathstone Holdings, LLC | 6K | $241K | 0.0% | 0.072% | 0.00% |
| 18 | UBS Group AG | 6K | $224K | +237.9% | 0.067% | 0.00% |
| 19 | Qube Research & Technologies Ltd | 6K | $223K | β | 0.067% | 0.00% |
| 20 | Vanguard Global Advisers, LLC | 1K | $51K | β | 0.015% | 0.00% |
| 21 | MORGAN STANLEY | 1K | $46K | +18.2% | 0.014% | 0.00% |
| 22 | ADVISOR GROUP HOLDINGS, INC. | 1K | $44K | -0.1% | 0.013% | 0.00% |
| 23 | Farther Finance Advisors, LLC | 283 | $11K | +1.4% | 0.003% | 0.00% |
| 24 | Strengthening Families & Communities, LLC | 173 | $7K | β | 0.002% | 0.00% |
| 25 | ROYAL BANK OF CANADA | 43 | $2K | β | 0.001% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in VTVT β a direct measure of their conviction.
Filings activity in VTVT during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 35 | +35% | 21.37% | +2.77 pp | $59M | +15% |
| Q4 2025 | 26 | +13% | 18.60% | +10.25 pp | $51M | +123% |
| Q3 2025 | 23 | +4.5% | 8.35% | +5.18 pp | $23M | +164% |
| Q2 2025 | 22 | +0.0% | 3.17% | 0.42 pp | $9M | 12% |
| Q1 2025 | 22 | +22% | 3.59% | +0.85 pp | $10M | +31% |
| Q4 2024 | 18 | 14% | 2.74% | +0.08 pp | $8M | +3.2% |
| Q3 2024 | 21 | +5.0% | 2.66% | +0.43 pp | $7M | +19% |
| Q2 2024 | 20 | β | 2.23% | β | $6M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying VTVT stock.
Based on Q1 2026 13F filings, institutional ownership of vTv Therapeutics Inc. stands at 21.4%, held across 35 reporting institutions.
Samsara BioCapital, LLC is the largest reported institutional holder of VTVT, with approximately 298,496 shares worth $0.01B as of Q1 2026.
Yes β 1 widely-followed marquee investor appear among the top 25 institutional holders of VTVT, including MILLENNIUM MANAGEMENT LLC.
Our composite Smart Money Score for VTVT is 67 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
13 institutions opened new positions in VTVT during Q1 2026, while 4 fully exited. 7 added to existing positions and 14 trimmed.
VTVT institutional ownership rose by 2.77 percentage points quarter-over-quarter, with a net change of +9 holders.
The top 10 institutions account for 93.6% of all reported 13F value in VTVT, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
vTv Therapeutics Inc. (VTVT) Institutional Ownership